Mounjaro (Tirzepatide)

Prescription medicineOnly Available By Prescription

Top brand choice

Strength Pack Size Qty
Pack Size
Pack Size
7.5mg Kwik Pen (4 doses)
Pack Size
10mg Kwik Pen (4 doses)
Pack Size
12.5mg Kwik Pen (4 doses)
Pack Size
15mg Kwik Pen (4 doses)
Pack Size

You'll have option to make 4 interest-free payments by credit card once your order is confirmed using

What if I find a lower price with another pharmacy?

We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!

Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.

To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.

Terms & Conditions of Program

  • Guaranteed lowest price is only valid at the time of sale.
  • We will only match the current advertised price.
  • Products must be identical and in stock at the time of placing an order with a licensed mail order pharmacy. They must be an online Canadian pharmacy with an address in Canada.
  • Products must be authentic in brand and size (same manufacturer, same country of manufacture, same pack size, same strength and same quantity).
  • Products must be new. We cannot match the price of any used, short expiry or expired product.
  • Price match can only be issued over the phone with our customer service team. Please note at this time we cannot offer price matching for the products Ozempic or Saxenda.
What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.


Mounjaro (tirzepatide) is an injectable medication used to treat type 2 diabetes in adults. It is used with diet and exercise. 

Patients who have had pancreatitis have not been studied while using Mounjaro. 

Patients with type 1 diabetes should not use Mounjaro. 

Fact Table







Legal status


Chemical Name


Elimination half-life

Five days

Dosage (Strength)



Insufficient data



Protein binding


PubChem CID






ATC code






Routes of administration



Mounjaro comes in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL single-use injectable pens.

The instructions that come with your Mounjaro prescription should be followed. If you have any questions or concerns, talk to your pharmacist or doctor. 

Mounjaro should only be used as instructed by your doctor. 

Inject Mounjaro under the skin of the abdomen, thigh, or upper arm. Switch injection sites with each use.

Mounjaro Dosage:

The recommended starting dose consists of the following: inject 2.5 mg subcutaneously once a week with or without food. After 4 weeks of treatment, increase to 5 mg subcutaneously one time a week. The dosage may be increased by 2.5 mg increments at 4-week intervals depending on medication response. Dosing should not exceed 15 mg one time a week. 


Tirzepatide, a glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist, is contained in Mounjaro.


If you or your family has a history of a type of thyroid cancer known as medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2, you should not use Mounjaro.

If you have an allergy to tirzepatide or any of the other ingredients or excipients contained in Mounjaro, avoid treatment with Mounjaro.



  • In both male and female rats, tirzepatide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether MOUNJARO causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined.

  • MOUNJARO is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk for MTC with the use of MOUNJARO and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness). Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with MOUNJARO. 


See full prescribing information for complete boxed warning.

  • Tirzepatide causes thyroid C-cell tumors in rats. It is unknown whether MOUNJARO causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined.

  • MOUNJARO is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC and symptoms of thyroid tumors.

  • Your medications, allergies, medical history and/or conditions, and plans to become pregnant or breastfeed should be discussed with your doctor before beginning treatment with Mounjaro. 
  • Pancreatitis may be caused by Mounjaro.
  • Low blood sugar may be caused by Mounjaro if used with insulin or another type of medication that can lower blood sugar. You should test your blood sugar levels and treat low blood sugar as your doctor has instructed.
  • Allergic reactions that can be severe may be induced by Mounjaro. Immediately seek medical attention if you develop shortness of breath, swelling of your face, lips, tongue, or throat, rash, or rapid heart rate.
  • Acute kidney damage can be caused by Mounjaro.
  • Gastrointestinal events that can be severe can be caused by Mounjaro.
  • Acute gallbladder disease can be caused by Mounjaro.
  • Monitor for complications or worsening symptoms in patients who have had diabetic retinopathy.

Side Effects

Nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain are the most common side effects associated with Mounjaro. 

Immediately call your doctor if you experience bothersome or persistent side effects. 


Mounjaro- tirzepatide injection, solution. Eli Lilly and Company; 2022.

Frequently Asked Questions about Mounjaro

What is Mounjaro?

Mounjaro is a weekly injection for adults with type 2 diabetes to lower blood sugar levels. It's used alongside diet and exercise.

Why is Mounjaro better than Ozempic?

Mounjaro is another option for type 2 diabetes treatment. It's pricier than Ozempic but may be more effective and might cause different side effects.

How does Mounjaro work?

Mounjaro works by imitating certain hormones to lower blood sugar levels when injected once a week.

Why does Mounjaro cause weight loss?

Mounjaro helps in weight loss by reducing food intake and slowing down digestion.

Do you have to take Mounjaro forever?

Usually, Mounjaro is for long-term management of type 2 diabetes. Your healthcare provider can give specific advice on how long you should use it.

How long does Mounjaro side effects last?

Side effects duration varies, lasting from days to weeks. Common ones include nausea, diarrhea, and abdominal pain.

How much weight do you lose on Mounjaro?

In studies, weight loss percentages varied based on the dose: 15% for 5mg, 19.5% for 10mg, and 20.9% for 15mg.

Is Mounjaro a controlled substance?

Mounjaro is not a controlled substance under the Controlled Substances Act. It's used for type 2 diabetes and obesity treatment.

What are the cons of taking Mounjaro?

Potential drawbacks of Mounjaro may include side effects like nausea, diarrhea, and decreased appetite.

IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

product-reviews Product Reviews